CAMFIL HVAC Filtration Solutions
NewsUncategorized

Tersano SAO Tested Against SARS-CoV-2 Surrogate

22.04.2020, 12:03

Tersano SAO Tested Against SARS-CoV-2 Surrogate

Tersano’s stabilized aqeous oxide (SAO™) cleaning solution has completed an initial round of independent testing against an approved surrogate for the SARS-CoV-2 virus.

The Coronavirus/MHV-3. MHV-3 (Murine coronavirus/Murine Hepatitis Virus) is an approved surrogate that belongs to the same Genus (Betacoronavirus) as SARS (SARS-CoV), MERS (MERS-CoV), and COVID-19 (SARS-CoV-2).

Tersano’s SAO solution was also tested against Influenza A Virus (H1N1), Measles Virus and Syncytial Respiratory Virus, with the manufacturer reporting it was effective in eliminating >99.99% (>4-log) of all four enveloped viruses with a one minute dwell time in a pathogen summary report.

The next stage of testing, which is expected in June, will involve SARS-CoV-2, the causative agent of COVID-19.

Author

  • Staff Reporter

    FMIndustry.com covers the latest news, trends and opinion from the facilities management (FM) and corporate real estate (CRE) sectors. The FM market is currently estimated to be worth USD 1 trillion annually and is projected to grow at a compounded annualised rate of approximately 5% between now and 2026.

CAMFIL HVAC Filtration Solutions

Staff Reporter

FMIndustry.com covers the latest news, trends and opinion from the facilities management (FM) and corporate real estate (CRE) sectors. The FM market is currently estimated to be worth USD 1 trillion annually and is projected to grow at a compounded annualised rate of approximately 5% between now and 2026.
Back to top button

We've noticed you are using an ad blocker

Advertising helps bring you fresh independent content. Please disable the adblock plugin or settings in your web browser to access the content you are trying to reach on www.fmindustry.com.